How severe is CVE-2017-12712?

CVE-2017-12712 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2017-12712 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (61st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2017-12712?

CVE-2017-12712 primarily affects Abbott Accent Firmware. In total, 7 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2017-12712?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2017-12712 published?

CVE-2017-12712 was published on 2018-04-25 and last updated on 2026-06-17.

CVE-2017-12712

CVE-2017-12712 is a high-severity vulnerability in Abbott Accent Firmware with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.

Key facts

Severity: High (CVSS 3.x base score 8.8)
CVSS v2: 8.3
EPSS exploit prediction: 1% (61st percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-287
Affected product: Abbott Accent Firmware
Published: 2018-04-25
Last modified: 2026-06-17

Description

The authentication algorithm in Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017, which involves an authentication key and time stamp, can be compromised or bypassed, which may allow a nearby attacker to issue unauthorized commands to the pacemaker via RF communications. CVSS v3 base score: 7.5, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.

Frequently asked questions

What is CVE-2017-12712?: The authentication algorithm in Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017, which involves an authentication key and time stamp, can be compromised or bypassed, which may allow a nearby attacker to issue unauthorized commands to the pacemaker via RF communications. CVSS v3 base score: 7.5, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.
How severe is CVE-2017-12712?: CVE-2017-12712 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2017-12712 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (61st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2017-12712?: CVE-2017-12712 primarily affects Abbott Accent Firmware. In total, 7 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2017-12712?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2017-12712 published?: CVE-2017-12712 was published on 2018-04-25 and last updated on 2026-06-17.

References

Affected products (7)

cpe:2.3:o:abbott:accent_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:abbott:anthem_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:abbott:accent_mri_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:abbott:accent_st_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:abbott:assurity_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:abbott:allure_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:abbott:assurity_mri_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Abbott Accent Firmware

CVE-2017-12716 — Medium (CVSS 6.5): Abbott Laboratories Accent and Anthem pacemakers manufactured prior to Aug 28, 2017 transmit unencrypted patient…
CVE-2017-12714 — Medium (CVSS 6.5): Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly…

All CVEs affecting Abbott Accent Firmware →

Other CWE-287 (Improper Authentication) vulnerabilities

CVE-2026-45480 — Critical (CVSS 10.0): Improper authentication in Azure Active Directory allows an unauthorized attacker to elevate privileges over a network.
CVE-2026-46389 — Critical (CVSS 10.0): UDS Identity Config builds the Keycloak configuration image (realm, plugins, theme, truststore, JARs) consumed by UDS…
CVE-2026-10611 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in MISP when LDAP mixed authentication is enabled with OTP enforcement.…
CVE-2026-47280 — Critical (CVSS 10.0): Improper authentication in Azure Resource Manager (ARM) allows an unauthorized attacker to elevate privileges over a…
CVE-2026-42822 — Critical (CVSS 10.0): Improper authentication in Azure Local Disconnected Operations allows an unauthorized attacker to elevate privileges…
CVE-2026-20182 — Critical (CVSS 10.0): May 2026: This security advisory provides the details and fix information for a vulnerability that was discovered and…

Browse all CWE-287 (Improper Authentication) vulnerabilities →